Detrol and Intervertebral disc space narrowing - a phase IV clinical study of FDA data

Summary:

Intervertebral disc space narrowing is reported as a side effect among people who take Detrol (tolterodine tartrate), especially for people who are female, 60+ old, also take Zometa, and have Prostate cancer metastatic.

The phase IV clinical study analyzes which people have Intervertebral disc space narrowing when taking Detrol. It is created by eHealthMe based on reports of 28,229 people who have side effects when taking Detrol from the FDA, and is updated regularly.

What is Detrol?

Detrol has active ingredients of tolterodine tartrate. It is often used in urge incontinence. eHealthMe is studying from 28,669 Detrol users. Check the latest studies of Detrol.

What is Intervertebral disc space narrowing?

Intervertebral disc space narrowing (spinal disc space narrowing) is found to be associated with 452 drugs and 315 conditions by eHealthMe. Check the latest studies of Intervertebral disc space narrowing.

On Jul, 08, 2026

28,229 people reported to have side effects when taking Detrol.
Among them, 24 people (0.09%) have Intervertebral disc space narrowing.

Could Detrol cause Intervertebral disc space narrowing?

Among these 24 people:

What is the gender of people who have Intervertebral disc space narrowing when taking Detrol? *

female: 60.87 %
male: 39.13 %

What is the age of people who have Intervertebral disc space narrowing when taking Detrol? *

What are other drugs people take besides Detrol? *

What are other side effects people have besides Intervertebral disc space narrowing? *

Intervertebral Disc Protrusion (spinal disc protrusion): 21 people, 87.50%
Fever: 18 people, 75.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 16 people, 66.67%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 66.67%
Pain: 16 people, 66.67%
Nausea (feeling of having an urge to vomit): 16 people, 66.67%
Dyspnea (difficult or laboured breathing): 15 people, 62.50%
Stress And Anxiety: 14 people, 58.33%
Nausea And Vomiting: 14 people, 58.33%
High Blood Pressure: 14 people, 58.33%

What are the existing conditions these people have? *

Prostate Cancer Metastatic: 6 people, 25.00%
Anaemia (lack of blood): 5 people, 20.83%
High Blood Pressure: 5 people, 20.83%
Hypercalcaemia (elevated calcium (ca+) level in the blood): 4 people, 16.67%
Metastases To Bone (cancer spreads to bone): 3 people, 12.50%
Inflammation: 3 people, 12.50%
Breast Cancer Metastatic: 3 people, 12.50%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 2 people, 8.33%
Osteoporosis (bones weak and more likely to break): 2 people, 8.33%
Fibromyalgia (a long-term condition which causes pain all over the body): 1 person, 4.17%

* Approximation only. Some reports may have incomplete information.

Do you take Detrol and have Intervertebral disc space narrowing?

- Check whether Intervertebral disc space narrowing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Detrol:

Detrol (28,669 reports)

Browse all side effects of Detrol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Intervertebral disc space narrowing:

Intervertebral disc space narrowing (452 drugs)

Browse all the conditions that are associated with Intervertebral disc space narrowing:

Intervertebral disc space narrowing (315 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tolterodine tartrate (the active ingredients of Detrol) and Detrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.